Research location

Voronezh

Russia

Published trials170
Site observations185
Linked trials published170
Page1 / 4
Advertisement

Research activity in Voronezh

Russia

CureCurrent currently publishes aggregate city-level research activity for this location: 170 trials and 185 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Voronezh

170 linked trials · page 1 of 4
Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in RussiaNCT06930859 · 2025-12-03 · 1 site observation
RECRUITING
Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry StudyNCT06521229 · 2024-06-27 · 1 site observation
RECRUITING
Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)NCT06472310 · 2024-06-06 · 1 site observation
RECRUITING
Left Ventricular Reverse Remodeling Evaluation After Surgical Correction of Aortic RegurgitationNCT06805253 · 2024-05-09 · 1 site observation
RECRUITING
Study of Patient With Frequent COPD ExacerbationsNCT07221981 · 2024-12-16 · 1 site observation
COMPLETED
PRospectIve ObseRvatIonal mulTicenter Study of Patients With Arterial hYpertension and CKD in the Population of RussiaNCT06372431 · 2024-04-27 · 1 site observation
COMPLETED
Exacerbations and Their Outcomes International (EXACOS International)NCT04928417 · 2021-11-26 · 1 site observation
COMPLETED
Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee OsteoarthritisNCT05064735 · 2021-10-01 · 1 site observation
COMPLETED
An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD ParticipantsNCT05013008 · 2021-08-18 · 2 site observations
COMPLETED
A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in RussiaNCT04943497 · 2021-07-27 · 1 site observation
COMPLETED
A 52-week, Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis (PILASTER)NCT04636801 · 2021-07-14 · 1 site observation
TERMINATED
A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)NCT04636814 · 2021-07-12 · 1 site observation
TERMINATED
A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)NCT04848480 · 2021-04-30 · 1 site observation
COMPLETED
Heart Failure Patients RegistryNCT04709263 · 2020-12-21 · 1 site observation
COMPLETED
A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin BeforeNCT04460885 · 2020-11-25 · 1 site observation
COMPLETED
A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid ArthritisNCT04497597 · 2020-10-16 · 1 site observation
COMPLETED
A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 DiabetesNCT04560998 · 2020-10-01 · 1 site observation
COMPLETED
A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy ,DR)NCT04477707 · 2020-07-23 · 2 site observations
COMPLETED
Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 InflammationNCT04456673 · 2020-07-06 · 1 site observation
COMPLETED
DIA_CENTRAL:T2D Treatment Pattern in Central EuropeNCT03807440 · 2019-08-26 · 4 site observations
COMPLETED
A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney DiseaseNCT03819153 · 2019-06-17 · 1 site observation
COMPLETED
Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant TreatmentNCT04000009 · 2019-06-06 · 1 site observation
TERMINATED
Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant TreatmentNCT03968159 · 2019-04-25 · 1 site observation
COMPLETED
A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 DiabetesNCT03740919 · 2019-04-07 · 1 site observation
COMPLETED
Mast Cells and Its Proteases in COPDNCT06392334 · 2019-01-29 · 1 site observation
UNKNOWN
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or ObesityNCT03574597 · 2018-10-24 · 1 site observation
COMPLETED
The Use of TrIple Fixed-dose Combination in the Treatment of Arterial HypertensionNCT03722524 · 2018-10-01 · 1 site observation
COMPLETED
COPD in Obese PatientsNCT04105075 · 2018-09-09 · 1 site observation
COMPLETED
A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat® InhalerNCT03663569 · 2018-08-15 · 2 site observations
COMPLETED
An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial AsthmaNCT04607629 · 2018-06-20 · 1 site observation
COMPLETED
STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or ObesityNCT03548935 · 2018-06-04 · 1 site observation
COMPLETED
A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT03474081 · 2018-03-29 · 1 site observation
COMPLETED
Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)NCT03345407 · 2017-11-28 · 1 site observation
TERMINATED
Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to FF Alone in Subjects With AsthmaNCT03248128 · 2017-10-20 · 1 site observation
COMPLETED
Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 DiabetesNCT03268005 · 2017-09-19 · 1 site observation
COMPLETED
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued TreatmentNCT02962414 · 2017-08-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a YearNCT02889809 · 2017-07-10 · 1 site observation
COMPLETED
Clinical Trial of Efficacy and Safety of Rengalin in the Treatment of Cough in Patients With Chronic Obstructive Pulmonary DiseaseNCT03159091 · 2017-06-16 · 1 site observation
COMPLETED
Study of Mepolizumab Autoinjector in AsthmaticsNCT03099096 · 2017-05-04 · 1 site observation
COMPLETED
Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With AsthmaNCT03012061 · 2017-01-25 · 1 site observation
COMPLETED
Extension Study of Pimavanserin for the Adjunctive Treatment of SchizophreniaNCT03121586 · 2017-01-01 · 1 site observation
TERMINATED
A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes MellitusNCT02973321 · 2016-12-02 · 1 site observation
COMPLETED
Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)NCT02970292 · 2016-10-26 · 1 site observation
COMPLETED
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise OnlyNCT02906930 · 2016-09-20 · 1 site observation
COMPLETED
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal ImpairmentNCT02827708 · 2016-09-20 · 1 site observation
COMPLETED
An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2NCT02756832 · 2016-09-20 · 1 site observation
COMPLETED
International Multicenter, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Participants With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of KazakhstanNCT02756819 · 2016-07-18 · 2 site observations
COMPLETED
Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPDNCT02766608 · 2016-05-31 · 1 site observation
COMPLETED
TRIple in Asthma hiGh strenGth vErsus Ics/Laba hs and tiotRopium (TRIGGER)NCT02676089 · 2016-04-06 · 1 site observation
COMPLETED
A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken MethotrexateNCT02706873 · 2016-02-23 · 1 site observation
COMPLETED
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.